Access to Behavioral Health

The Food and Drug Administration approved the first pill to treat postpartum depression in adults, whose symptoms can range from sadness and loss of energy to cognitive impairment and suicidal ideation. Patients would take the drug (Zurzuvae) for 14 days.
For years, many commercial health insurers treated coverage for mental health or substance use disorders (SUD) very differently than for medical and surgical benefits.
The Substance Abuse and Mental Health Services Administration released a report reviewing the four principal funding sources for states to finance coordinated specialty care and other team-based behavioral health services for patients experiencing first episode psychosis, the early period of…
The departments of the Treasury, Labor and Health and Human Services July 25 issued a proposed rule related to the enforcement of the Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008.
The departments of Labor, Health and Human Services and the Treasury released a proposed rule that seeks to ensure commercial health plans comply with the Mental Health Parity and Addiction Equity Act of 2008, which prohibits them from imposing more restrictive requirements on mental health or…
The Substance Abuse and Mental Health Services Administration seeks comments through 5 p.m. Aug. 14 on its draft framework to integrate harm reduction strategies across its initiatives and partnerships for people who use drugs.
The Centers for Medicare & Medicaid Services approved Medicaid state plan amendments for California and Kentucky to provide 24/7 community-based mobile crisis intervention services to eligible individuals experiencing a mental health or substance use crisis, as authorized by the American Rescue…
The House Energy and Commerce Committee passed 15 health-related bills approved by its health subcommittee last week, including bills that would reauthorize the Pandemic and All-Hazards Preparedness Act, Children’s Hospitals Graduate Medical Education Program, and key programs within the Substance…